Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Net Income (Common) Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Net Income (Common)
-AU$8.7m
CAGR 3-Years
-20%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Net Income (Common)
-AU$174.2m
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Net Income (Common)
AU$117.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Net Income (Common)
-AU$13.9m
CAGR 3-Years
-61%
CAGR 5-Years
4%
CAGR 10-Years
-28%
Probiotec Ltd
ASX:PBP
Net Income (Common)
AU$8.7m
CAGR 3-Years
29%
CAGR 5-Years
-11%
CAGR 10-Years
21%
Vita Life Sciences Ltd
ASX:VLS
Net Income (Common)
AU$9.4m
CAGR 3-Years
12%
CAGR 5-Years
44%
CAGR 10-Years
3%

See Also

What is Arovella Therapeutics Ltd's Net Income (Common)?
Net Income (Common)
-8.7m AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Net Income (Common) amounts to -8.7m AUD.

What is Arovella Therapeutics Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-2%

Over the last year, the Net Income (Common) growth was 14%. The average annual Net Income (Common) growth rates for Arovella Therapeutics Ltd have been -20% over the past three years , -2% over the past five years .

Back to Top